<DOC>
	<DOCNO>NCT00245791</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness antibiotic levofloxacin administer high dose levofloxacin use short course therapy .</brief_summary>
	<brief_title>Urinary Tract Infection Study With Antibiotic Levofloxacin Given Higher Dose Over Shorter Period Time</brief_title>
	<detailed_description>This study pilot study efficacy 750 mg levofloxacin daily 5 day treatment complicate urinary tract infection . The specific objective include : 1 . To describe clinical microbiological outcome short long term follow-up 5 day levofloxacin subject acute symptomatic complicate urinary infection , without indwell catheter . 2 . To determine tolerability levofloxacin 750-mg daily patient complicate urinary infection . 3 . To describe characteristic resolution inflammatory response treatment complicate urinary infection demonstrate change urine protein . 4 . To identify emergence resistant organisms recurrent urinary infection follow therapy .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>1 . Acute symptoms urinary infection le 7 day duration underlying structural functional abnormality genitourinary tract . 2 . Pretherapy urine culture &gt; 105 cfu/ml ( &gt; 108 cfu/L ) least one urinary pathogen . 3 . Age 1880 year , male female . 1 . Prior allergic reaction fluoroquinolone antimicrobial . 2 . Known infection fluoroquinolone resistant organism . 3 . Requiring parenteral therapy severity illness unable take oral medication . 4 . Women pregnant breastfeeding . 5 . Requiring additional antimicrobial therapy infection elsewhere .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>Complicated Urinary Infection</keyword>
</DOC>